Clinical Trial Update: Adalimumab in Rheumatoid Arthritis. An Investigation of Wholebody MRI, Conventional MRI, CT and Circulating Biomarkers

View source ↗

Summary

This trial update reports a completed study evaluating adalimumab in rheumatoid arthritis, incorporating whole-body MRI, conventional MRI, CT, and circulating b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Glostrup University Hospital, Copenhagen | Conditions: Rheumatoid Arthritis | Status: COMPLETED